Agents for treating disorders involving modulation of ryanodine receptors
The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BERTRAND MARC VILLENEUVE NICOLE WEBB YAEL YAN JIAMING BELVEDERE SANDRO |
description | The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN104350045A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN104350045A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN104350045A3</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHPxIOof1gcIkbYPKEXRiyfvJTSbEoi7YXct-HsVfICngZlZu2s_I5lCYgETDJZphpiVJaIoZFq4LF_34Pgsn8wEnEBegThmQhCcsBqLbt0qhaK4-3Hj9ufTfbgcsPKIWsOEhDYOt6Nvm877tuubf543Rwc1fw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Agents for treating disorders involving modulation of ryanodine receptors</title><source>esp@cenet</source><creator>BERTRAND MARC ; VILLENEUVE NICOLE ; WEBB YAEL ; YAN JIAMING ; BELVEDERE SANDRO</creator><creatorcontrib>BERTRAND MARC ; VILLENEUVE NICOLE ; WEBB YAEL ; YAN JIAMING ; BELVEDERE SANDRO</creatorcontrib><description>The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150211&DB=EPODOC&CC=CN&NR=104350045A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150211&DB=EPODOC&CC=CN&NR=104350045A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BERTRAND MARC</creatorcontrib><creatorcontrib>VILLENEUVE NICOLE</creatorcontrib><creatorcontrib>WEBB YAEL</creatorcontrib><creatorcontrib>YAN JIAMING</creatorcontrib><creatorcontrib>BELVEDERE SANDRO</creatorcontrib><title>Agents for treating disorders involving modulation of ryanodine receptors</title><description>The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQAHPxIOof1gcIkbYPKEXRiyfvJTSbEoi7YXct-HsVfICngZlZu2s_I5lCYgETDJZphpiVJaIoZFq4LF_34Pgsn8wEnEBegThmQhCcsBqLbt0qhaK4-3Hj9ufTfbgcsPKIWsOEhDYOt6Nvm877tuubf543Rwc1fw</recordid><startdate>20150211</startdate><enddate>20150211</enddate><creator>BERTRAND MARC</creator><creator>VILLENEUVE NICOLE</creator><creator>WEBB YAEL</creator><creator>YAN JIAMING</creator><creator>BELVEDERE SANDRO</creator><scope>EVB</scope></search><sort><creationdate>20150211</creationdate><title>Agents for treating disorders involving modulation of ryanodine receptors</title><author>BERTRAND MARC ; VILLENEUVE NICOLE ; WEBB YAEL ; YAN JIAMING ; BELVEDERE SANDRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN104350045A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BERTRAND MARC</creatorcontrib><creatorcontrib>VILLENEUVE NICOLE</creatorcontrib><creatorcontrib>WEBB YAEL</creatorcontrib><creatorcontrib>YAN JIAMING</creatorcontrib><creatorcontrib>BELVEDERE SANDRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BERTRAND MARC</au><au>VILLENEUVE NICOLE</au><au>WEBB YAEL</au><au>YAN JIAMING</au><au>BELVEDERE SANDRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Agents for treating disorders involving modulation of ryanodine receptors</title><date>2015-02-11</date><risdate>2015</risdate><abstract>The present invention relates to 1,4-benzothiazepine derivatives and their use to treat conditions, disorders and diseases associated with ryanodine receptors (RyRs) that regulate calcium channel functioning in cells. The invention also discloses pharmaceutical compositions comprising the compounds and uses thereof to treat diseases and conditions associated with RyRs, in particular cardiac, musculoskeletal and central nervous system (CNS) disorders.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_CN104350045A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Agents for treating disorders involving modulation of ryanodine receptors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T12%3A56%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BERTRAND%20MARC&rft.date=2015-02-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN104350045A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |